Analysis of ingestion admissions in a midsized pediatric intensive care unit

Hayden L Smith1,2,3, Kaitlin A Branick2, Margaret E Free3

  • 1Unitypoint Health, Des Moines, IA 50309, USA.

Insights

Pediatric toxic ingestions lead to hospitalizations, with intentional ingestion more common in older children. This study quantified costs and characteristics of these admissions, finding short stays and no mortality.

Area of Science:

  • Toxicology
  • Pediatric Critical Care
  • Public Health

Background:

  • Pediatric ingestion of toxic substances is a significant cause of illness.
  • Limited research exists on toxic ingestions leading to pediatric intensive care unit (PICU) admissions.

Purpose of the Study:

  • To quantify the incidence and financial costs of toxic ingestion admissions to a PICU.
  • To identify common ingestions, interventions, and the relationship between intentional ingestion and patient age.

Main Methods:

  • Retrospective study of PICU records from April 2016 to August 2018 in the Midwestern USA.
  • Analysis of 360 unique patient encounters for toxic ingestions.
  • Examination of ingestion types, interventions, intentionality, and patient demographics.

Main Results:

  • Intentional ingestion and suicidal ideation were documented in 72% and 54% of patients, respectively.
  • Patients under nine years old had a significantly lower risk of intentional ingestion (87% lower risk).
  • Median length of stay was 1.0 day with a median cost of $2498 USD; no mortality was observed.

Conclusions:

  • Ingestion types align with national data.
  • PICU admissions for toxic ingestions were associated with short stays and considerable costs.
  • Older age correlated with a higher risk of intentional ingestion in pediatric patients.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
34
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
49
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
36
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
39
One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance00:56

One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance

Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
169
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
353